University of Arizona, USA
Dr. Prashansha Agrawal is working on anticancer drug targets for quite a couple of years. She has received her PhD degree from Indian Institute of Technology Roorkee, India, where she worked on drug-DNA interaction studies to find out the potential targets for anticancer drugs, which may provide an insight into the rationale for structurally based drug design. After that she joined University of Tennessee as postdoc, where she worked on soluble CD14 (sCD14), which is a serum glycol protein that binds to the Lipid A moiety of lipopolysaccharides (LPS) with high affinity as part of the innate immune response to bacterial endotoxins. Now she has joined University of Arizona and she is working on structure elucidation of DNA G-quadruplex secondary structure that has recently emerged as a new class of cancer-specific molecular targets for cancer therapeutics. Her work is published in peer-reviewed journals and she has been a reviewer for few scientific journals.
Structural biology, computational biology, drug discovery and development, pharmacology, molecular biology, NMR spectroscopy, Chemical Biology, Biophysics, macromolecular interactions